Partner diligence
Give prospective partners an inspectable explanation of the proposed mechanism, supporting evidence and unresolved scientific questions before discussing fit and development plans.
Scientific videos · Interactive websites · Academic figures
Prepare prospective partners and investors to evaluate your lead program
Scientific videos, interactive websites and academic figures for biotech leadership preparing for partnering, scientific diligence and fundraising discussions.
Make the lead program easier to assess before the meeting
Ahead of a partnering meeting or fundraising discussion, prospective partners and investors need to understand the clinical problem, proposed mechanism, evidence available today and the next development question. A 3-minute scientific film introduces that sequence before the conversation. An interactive website lets the recipient inspect the mechanism and source context afterwards, while two academic figures give your leadership team a consistent explanation for its presentation.
For a preclinical or early clinical program, the brief should distinguish a hypothesis, a laboratory result and a clinical result. We agree on what the current evidence can support before production; the visual treatment should not imply that an unanswered question is resolved.
Build around a real use
Program website
Give scientists and prospective partners an accessible explanation with source context.
Investor discussions
Introduce the biology and development question using the same reviewed scientific material as your team.
The project outputs
A 3-minute scientific video
Explain unmet need, drug science and clinical results through a narrated sequence.
An interactive website
Let visitors explore the mechanism, inspect the evidence and follow the references.
Two academic figures
A mechanism figure and a clinical-results figure, with editable SVG, vector PDF and PNG exports.
Inspect the existing demonstrations
Independently produced examples of scientific communication, not commissioned client case studies. Existing demonstration lengths and supporting materials vary.
Antibody–drug conjugate · HER2T-DM1
Follow an antibody–drug conjugate from the tumor environment to receptor binding, internalization and lysosomal processing. Then examine the clinical evidence separately from the illustrated mechanism.
View the example →
Small molecule · RAS(ON)Daraxonrasib
Move from pancreatic tumor context to the molecular binding arrangement, then inspect the clinical evidence and its source notes. The demonstration separates structural evidence from authored movement.
View the example →
Cell therapy · CD19Tisagenlecleucel
Follow a living cell therapy through tissue context, target recognition and a directed response. Pair the guided film with an interactive explanation, a labeled mechanism figure and a clinical evidence brief.
View the example →From scientific brief to finished outputs
- Define the brief. Agree on the program, audience, question, evidence and deadline.
- Review the science. Develop a script and storyboard with references and explicit representation limits.
- Build the formats. Produce the film, interactive experience and figures around the reviewed explanation.
- Review and deliver. Work through the agreed scientific reviews and package the final outputs.
What should your audience understand?
Tell us about the program, audience, scientific question and timeline.
Discuss your project ↗